Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion type Assertion NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_head.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion description "[We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_provenance.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion evidence source_evidence_literature NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_provenance.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion SIO_000772 14610337 NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_provenance.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion wasDerivedFrom befree-2016 NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_provenance.
- NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_assertion wasGeneratedBy ECO_0000203 NP420091.RAekqD6FjQyYK5U1JhoVmAmjojRvy_g5g9Wjh1jreFRKM130_provenance.